Key points are not available for this paper at this time.
Interest in α-emitters for radiotherapeutic applications is on the rise. However, the number of options for α-emitters with midterm industrial availability remains limited. Currently, only 225Ac, 212Pb, and 211At have realistic chances to reach the market within the next 10 y. A review published
Richard Zimmermann (Thu,) studied this question.